Related Articles
Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer
Effect of valproic acid on histone deacetylase expression in oral cancer (Review)
Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells
Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells
Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues